This Article Full Text Full Text (PDF) All Versions of this Article: 37/6/1490    most recent 01.STR.0000221787.70503.cav1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hallemeier, C. L. Articles by Derdeyn, C. P. Search for Related Content PubMed PubMed Citation Articles by Hallemeier, C. L. Articles by Derdeyn, C. P. Related Collections By-pass procedures

(Stroke. 2006;37:1490.)
© 2006 American Heart Association, Inc.

Original Contributions

Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon

Christopher L. Hallemeier, BA; Keith M. Rich, MD; Robert L. Grubb, Jr, MD; Michael R. Chicoine, MD; Christopher J. Moran, MD; DeWitte T. Cross, III, MD; Gregory J. Zipfel, MD; Ralph G. Dacey, Jr, MD Colin P. Derdeyn, MD

From the Interventional Neuroradiology Section (C.L.H., C.P.D., C.J.M., D.T.C.), Mallinckrodt Institute of Radiology, and the Departments of Neurological Surgery (C.P.D., K.M.R., R.L.G., M.R.C., C.J.M., D.T.C., G.J.Z., R.G.D.), and Neurology (C.P.D., G.J.Z.), Washington University School of Medicine, St Louis, Mo.

Correspondence to Colin P. Derdeyn, MD, Washington University School of Medicine, 510 South Kingshighway Boulevard, St Louis, MO 63110. E-mail derdeync{at}wustl.edu

Background and Purpose— To describe baseline clinical features and outcomes of adults with moyamoya phenomenon treated at a single North American institution.

Methods— We identified 34 adults with moyamoya phenomenon by review of angiographic records. Clinical presentation and baseline stroke risk factors were obtained by chart review. Follow-up was obtained prospectively. A 5-year Kaplan-Meier stroke risk was calculated.

Results— The median age was 42 (range 20 to 79) years. Twenty-five were women. The initial symptom was ischemia, hemorrhage, or asymptomatic in 24, 7, and 3 patients, respectively. Twenty-two had bilateral involvement and 12 had unilateral moyamoya vessels. Baseline stroke risk factors were similar between groups. The median follow-up in 31 living patients was 5.1 (range 0.2 to 19.6) years. Fourteen patients were treated with surgical revascularization (20 total hemispheres). In medically treated symptomatic hemispheres, the 5-year risk of recurrent ipsilateral stroke was 65% after the initial symptom and 27% after angiographic diagnosis. Patients with bilateral involvement presenting with ischemic symptoms were at the highest risk of subsequent stroke (n=17, 5-year risk of stroke with medical treatment after first symptom of 82%). In surgically treated hemispheres, the 5-year risk of perioperative or subsequent ipsilateral stroke or death was 17%. This was significantly different compared with medical treatment after first symptom (P=0.02) but not after angiographic diagnosis.

Conclusion— Moyamoya phenomenon in North American adults is associated with a high risk of recurrent stroke, particularly those with bilateral involvement and ischemic symptoms. These data suggest a potential benefit with surgery if diagnosis could be made earlier.

Key Words: cerebral hemorrhage • cerebral infarction • cerebral revascularization • Moyamoya disease • retrospective studies

This article has been cited by other articles:

				S. Kuriyama, Y. Kusaka, M. Fujimura, K. Wakai, A. Tamakoshi, S. Hashimoto, I. Tsuji, Y. Inaba, and T. Yoshimoto Prevalence and Clinicoepidemiological Features of Moyamoya Disease in Japan: Findings From a Nationwide Epidemiological Survey Stroke, January 1, 2008; 39(1): 42 - 47. [Abstract] [Full Text] [PDF]